Seattle, WA, United States of America

Kineta Two, LLC

Calculating rank
USPTO Granted Patents = 11

% Expired Patents = 100.0


Forward Citations = 12

Loading Chart...
Loading Chart...

10 inventors (with patents filed for the assignee):

goldMedal Shawn P Iadonato (11 out of 29 patents)

silverMedal Christina A Scherer (11 out of 12 patents)

bronzeMedal Charles Lee Magness (11 out of 15 patents)

4.  Gary Rosenberg (4 out of 5 patents)

5.  Thierry Guillaudeux (4 out of 4 patents)

6.  Mark Branum (4 out of 5 patents)

7.  Maralee McVean (4 out of 7 patents)

8.  Tory Hagen (3 out of 3 patents)

9.  Amy Olson (3 out of 3 patents)

10.  P Campion Fellin (3 out of 3 patents)

11.  Charles L Magness (0 patent)


11 patents:

Company Overview
Kineta Two, LLC is a Seattle-based company specializing in advanced technologies for the development of innovative therapeutic solutions. The organization focuses on research and development in the fields of biotechnology and pharmaceuticals, aiming to address unmet medical needs through cutting-edge science. With a commitment to enhancing healthcare outcomes, Kineta Two leverages its expertise to create novel treatments that improve patient quality of life, positioning itself as a key player in the evolving landscape of medical innovation.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Nov 17 2026

11 Patents

#184 in Seattle, WA

#632 in Washington

#27,615 in US

#51,989 in the World

Seattle, WA (US)
Seattle, WA, United States of America
Forward Citations = 12

10 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Kineta Two, LLC. Retrieved from https://idiyas.com/company/kineta-two

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…